AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2014
Sep 23, 2014
35124_dirs_2014-09-23_0849a0f6-1c1f-44da-8b7a-05f821d03058.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-02-11
Reporting Person: Tardugno Michael H (Director, CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-02-11 | Option to Purchase Celsion Corporation Common Stock | $3.66 | A | 44444 | Acquired | 2024-02-11 | Celsion Corporation Common Stock (44444) | Direct |
Footnotes
F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.
F2: The option vests in thirds on February 11, 2014, February 11, 2015 and February 11, 2016.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18